Albrecht Stenzinger, MD
Albrecht Stenzinger, MD
Institute of Pathology, University Hospital Heidelberg, Germany
Bestätigte E-Mail-Adresse bei
Zitiert von
Zitiert von
Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
TA Chan, M Yarchoan, E Jaffee, C Swanton, SA Quezada, A Stenzinger, ...
Annals of Oncology 30 (1), 44-56, 2019
Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay
I Baccelli, A Schneeweiss, S Riethdorf, A Stenzinger, A Schillert, V Vogel, ...
Nature biotechnology 31 (6), 539-544, 2013
Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group
F Mosele, J Remon, J Mateo, CB Westphalen, F Barlesi, MP Lolkema, ...
Annals of Oncology 31 (11), 1491-1505, 2020
Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
A Vogel, A Cervantes, I Chau, B Daniele, JM Llovet, T Meyer, JC Nault, ...
Annals of oncology 29, iv238-iv255, 2018
The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma …
A Warth, T Muley, M Meister, A Stenzinger, M Thomas, P Schirmacher, ...
Journal of clinical oncology 30 (13), 1438-1446, 2012
SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas
JA Müller, R Groß, C Conzelmann, J Krüger, U Merle, J Steinhart, T Weil, ...
Nature metabolism 3 (2), 149-165, 2021
Tumor mutational burden as a predictive biomarker in solid tumors
D Sha, Z Jin, J Budczies, K Kluck, A Stenzinger, FA Sinicrope
Cancer discovery 10 (12), 1808-1825, 2020
Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends …
DM Merino, LM McShane, D Fabrizio, V Funari, SJ Chen, JR White, ...
Journal for immunotherapy of cancer 8 (1), 2020
Sarcoma classification by DNA methylation profiling
C Koelsche, D Schrimpf, D Stichel, M Sill, F Sahm, DE Reuss, M Blattner, ...
Nature communications 12 (1), 498, 2021
The landscape of metastatic progression patterns across major human cancers
J Budczies, M von Winterfeld, F Klauschen, M Bockmayr, JK Lennerz, ...
Oncotarget 6 (1), 570, 2015
Detection and segmentation of cell nuclei in virtual microscopy images: a minimum-model approach
S Wienert, D Heim, K Saeger, A Stenzinger, M Beil, P Hufnagl, M Dietel, ...
Scientific reports 2 (1), 503, 2012
Classification of cancer at prostate MRI: deep learning versus clinical PI-RADS assessment
P Schelb, S Kohl, JP Radtke, M Wiesenfarth, P Kickingereder, ...
Radiology 293 (3), 607-617, 2019
Prognostic impact of tumour-infiltrating immune cells on biliary tract cancer
B Goeppert, L Frauenschuh, M Zucknick, A Stenzinger, M Andrulis, ...
British journal of cancer 109 (10), 2665-2674, 2013
Accurate and efficient detection of gene fusions from RNA sequencing data
S Uhrig, J Ellermann, T Walther, P Burkhardt, M Fröhlich, B Hutter, ...
Genome research 31 (3), 448-460, 2021
BRAFV600E mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosis
F Sahm, D Capper, M Preusser, J Meyer, A Stenzinger, F Lasitschka, ...
Blood, The Journal of the American Society of Hematology 120 (12), e28-e34, 2012
Integrative genomic and transcriptomic analysis of leiomyosarcoma
P Chudasama, SS Mughal, MA Sanders, D Hübschmann, I Chung, ...
Nature communications 9 (1), 144, 2018
Increased microtubule assembly rates influence chromosomal instability in colorectal cancer cells
N Ertych, A Stolz, A Stenzinger, W Weichert, S Kaulfuß, P Burfeind, ...
Nature cell biology 16 (8), 779-791, 2014
NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer
C Heining, P Horak, S Uhrig, PL Codo, B Klink, B Hutter, M Fröhlich, ...
Cancer discovery 8 (9), 1087-1095, 2018
CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma
EM Noll, C Eisen, A Stenzinger, E Espinet, A Muckenhuber, C Klein, ...
Nature medicine 22 (3), 278-287, 2016
Tumor mutational burden standardization initiatives: recommendations for consistent tumor mutational burden assessment in clinical samples to guide immunotherapy treatment …
A Stenzinger, JD Allen, J Maas, MD Stewart, DM Merino, MM Wempe, ...
Genes, Chromosomes and Cancer 58 (8), 578-588, 2019
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20